ISSAC Corp recognized for pancreatic cancer work in the British Journal of Cancer

“Genomic results, treatment reports and outcome data from trials 20206-001 and 20206-003 were fused and analysed using The Health Analytic (THA) powered by ILLUMINATIVE Analytics (ISSAC Corp).”

 

Read the full article at nature.com